Free Trial

AlloVir (ALVR) SEC Filings & 10K Form

$0.80
+0.03 (+3.92%)
(As of 05/21/2024 ET)

Recent AlloVir SEC Filings

DateFilerForm TypeView
05/17/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
3:00 PM
AlloVir (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/23/2024
3:05 PM
AlloVir (Filer)
Form DEF 14A
04/23/2024
3:06 PM
AlloVir (Filer)
Form DEFA14A
04/23/2024
3:08 PM
AlloVir (Filer)
Form ARS
04/23/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
6:30 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2024
6:30 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2024
6:30 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2024
6:30 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
7:43 AM
AlloVir (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
3:16 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
3:18 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:22 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
4:30 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
4:30 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
4:30 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
3:30 PM
AlloVir (Filer)
Form RW
02/09/2024
7:01 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This Could be Your “Big Money” AI Moment (Ad)

BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts.

Starting today, you could siphon a new stream of income from this $3 billion pool of cash.
02/09/2024
4:12 PM
AlloVir (Subject)
Artal International S.C.A. (Filed by)
Form SC 13G/A
02/09/2024
7:35 AM
AlloVir (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/08/2024
4:01 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2024
3:38 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
3:39 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
3:40 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
3:46 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
4:11 PM
AlloVir (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G
01/23/2024
7:30 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
7:30 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
7:30 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
7:30 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
11:32 AM
AlloVir (Subject)
Wilson John Robert (Filed by)
Form SC 13G/A
01/09/2024
11:29 AM
AlloVir (Subject)
Wilson John Robert (Filed by)
Form SC 13G
01/08/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
5:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
5:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
5:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
4:21 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
6:36 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
6:07 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
4:30 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
4:30 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
4:30 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
7:11 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
4:00 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
4:00 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
4:00 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2023
4:20 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/20/2023
4:29 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/19/2023
4:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/19/2023
4:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/19/2023
4:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/05/2023
4:00 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
4:00 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
4:00 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
4:56 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2023
4:49 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2023
4:50 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2023
4:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/17/2023
4:07 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/17/2023
4:10 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Must-See: Elon’s New Invention is Absolutely Insane (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…
08/03/2023
6:34 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2023
6:23 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
6:17 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
5:51 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/06/2023
4:00 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
4:00 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:49 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2023
4:17 PM
AlloVir (Issuer)
GILEAD SCIENCES, INC. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:14 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ALVR) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners